2020
DOI: 10.1111/aos.14604
|View full text |Cite
|
Sign up to set email alerts
|

Silicone oil in vitreoretinal surgery: indications, complications, new developments and alternative long‐term tamponade agents

Abstract: Silicone oil (SO) has been used as a long-term tamponade agent in the treatment of complicated vitreoretinal diseases for about half a century, during which time many advances in surgical techniques and technologies have been made. This review summarizes the chemical and physical properties of SO, its indications and complications, including particularly emulsification. The mechanisms and risk factors for emulsification are discussed, as well as novel strategies for its effective removal. Finally, the review f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(50 citation statements)
references
References 132 publications
(179 reference statements)
0
50
0
Order By: Relevance
“…SilOil has been used as a long-term endo-ocular tamponade agent since 1962, and is still currently indispensable in the treatment of complicated vitreoretinal diseases [ 20 ]. However, the long-term presence of SilOil in the vitreous cavity may cause a variety of complications, especially retinal toxicity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…SilOil has been used as a long-term endo-ocular tamponade agent since 1962, and is still currently indispensable in the treatment of complicated vitreoretinal diseases [ 20 ]. However, the long-term presence of SilOil in the vitreous cavity may cause a variety of complications, especially retinal toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…Four linear LMWCs, namely methyldisiloxane (L2) (#52630, MW = 162.38), octamethyltrisiloxane (L3) (#469319, MW = 236.53), decamethyltetrasiloxane (L4) (#235679, MW = 310.69), dodecamethylpentasiloxane (L5) (#447269, MW = 384.84) and two cyclic LMWCs, octamethylcyclotetrasiloxane (D4) (#235695, MW = 296.62) and decamethylcyclopentasiloxane (D5) (#444278, MW = 370.77) were tested in this study. Silicone oil with a viscosity of 1000 cSt is one of the most commonly used SilOils in ophthalmic surgeries [ 20 ]. Therefore, silicone oil 1000 cSt (1000 cSt SilOil) was used as the control SilOil (#378399).…”
Section: Methodsmentioning
confidence: 99%
“…However, several complications arise with the long-term use of SO as vitreous substitute which includes its emulsification resulting in cataract formation, glaucoma, corneal toxicity, band keratopathy [ 60 , 61 ]. In order to avoid these complications, surgical removal of silicone oil becomes a necessity, although risk of retinal detachment is associated with the removal process.…”
Section: Currently Used Vitreous Substitutes In Clinicsmentioning
confidence: 99%
“… 3 Repeated retinal detachment will lead to SO dependence, 4 which requires extended maintenance of the prone position. Long-term SO tamponade can lead to complications such as corneal degeneration, emulsification, cataracts, 5 , 6 early hypertension, and secondary glaucoma. 7 , 8 Studies concerning the effects of long-term SO tamponade on intraocular pressure (IOP) have implied that this treatment may lead to reduced choroidal thickness; 9 11 SO‐related retinal toxicity and visual loss have also been observed.…”
Section: Introductionmentioning
confidence: 99%
“… 6 , 12 SO emulsification is the most important limitation of long-term in situ SO tamponade because it is considered a fundamental source of SO-related complications. 5 Emulsification is associated with the development of keratopathy, delayed glaucoma, and optic neuropathy through mechanisms including emulsion oil droplet contact with the corneal endothelium, trabecular network inflammation, and direct SO infiltration into the atrial angular structure. Despite its complications, SO tamponade remains suitable for patients with severe ocular trauma.…”
Section: Introductionmentioning
confidence: 99%